Introduction {#jcmm12711-sec-0001}
============

Telocytes (TCs) represent a distinct interstitial cell population that is present in a wide variety of human and mammalian reproductive organs/tissues, including non‐pregnant and pregnant myometrium, oviduct and placenta [1](#jcmm12711-bib-0001){ref-type="ref"}, [2](#jcmm12711-bib-0002){ref-type="ref"}, [3](#jcmm12711-bib-0003){ref-type="ref"}, [4](#jcmm12711-bib-0004){ref-type="ref"}, [5](#jcmm12711-bib-0005){ref-type="ref"}, [6](#jcmm12711-bib-0006){ref-type="ref"}, [7](#jcmm12711-bib-0007){ref-type="ref"}, [8](#jcmm12711-bib-0008){ref-type="ref"}, [9](#jcmm12711-bib-0009){ref-type="ref"}, [10](#jcmm12711-bib-0010){ref-type="ref"}, [11](#jcmm12711-bib-0011){ref-type="ref"}, [12](#jcmm12711-bib-0012){ref-type="ref"}, [13](#jcmm12711-bib-0013){ref-type="ref"}, [14](#jcmm12711-bib-0014){ref-type="ref"}, [15](#jcmm12711-bib-0015){ref-type="ref"}, [16](#jcmm12711-bib-0016){ref-type="ref"}, [17](#jcmm12711-bib-0017){ref-type="ref"}, [18](#jcmm12711-bib-0018){ref-type="ref"}, [19](#jcmm12711-bib-0019){ref-type="ref"}, [20](#jcmm12711-bib-0020){ref-type="ref"}, [21](#jcmm12711-bib-0021){ref-type="ref"}, [22](#jcmm12711-bib-0022){ref-type="ref"}, [23](#jcmm12711-bib-0023){ref-type="ref"}, [24](#jcmm12711-bib-0024){ref-type="ref"}, [25](#jcmm12711-bib-0025){ref-type="ref"}, with multiple proposed potential biological functions. Telocytes have extremely long, thin cytoplasmic extensions called telopodes (Tps) that provide a visible direct structural support for homocellular or heterocellular junctions, potentially contributing to the maintenance of local homeostasis, tissue repair/remodelling and intercellular signalling [26](#jcmm12711-bib-0026){ref-type="ref"}, [27](#jcmm12711-bib-0027){ref-type="ref"}, [28](#jcmm12711-bib-0028){ref-type="ref"}, [29](#jcmm12711-bib-0029){ref-type="ref"}, [30](#jcmm12711-bib-0030){ref-type="ref"}, [31](#jcmm12711-bib-0031){ref-type="ref"}, [32](#jcmm12711-bib-0032){ref-type="ref"}, [33](#jcmm12711-bib-0033){ref-type="ref"}, [34](#jcmm12711-bib-0034){ref-type="ref"}, [35](#jcmm12711-bib-0035){ref-type="ref"}, [36](#jcmm12711-bib-0036){ref-type="ref"}, [37](#jcmm12711-bib-0037){ref-type="ref"}, [38](#jcmm12711-bib-0038){ref-type="ref"}, [39](#jcmm12711-bib-0039){ref-type="ref"}, [40](#jcmm12711-bib-0040){ref-type="ref"}, [41](#jcmm12711-bib-0041){ref-type="ref"}, [42](#jcmm12711-bib-0042){ref-type="ref"}, [43](#jcmm12711-bib-0043){ref-type="ref"}, [44](#jcmm12711-bib-0044){ref-type="ref"}, [45](#jcmm12711-bib-0045){ref-type="ref"}, [46](#jcmm12711-bib-0046){ref-type="ref"}, [47](#jcmm12711-bib-0047){ref-type="ref"}, [48](#jcmm12711-bib-0048){ref-type="ref"}, [49](#jcmm12711-bib-0049){ref-type="ref"}, [50](#jcmm12711-bib-0050){ref-type="ref"}, [51](#jcmm12711-bib-0051){ref-type="ref"}, [52](#jcmm12711-bib-0052){ref-type="ref"}, [53](#jcmm12711-bib-0053){ref-type="ref"}, [54](#jcmm12711-bib-0054){ref-type="ref"}, [55](#jcmm12711-bib-0055){ref-type="ref"}, [56](#jcmm12711-bib-0056){ref-type="ref"}, [57](#jcmm12711-bib-0057){ref-type="ref"}, [58](#jcmm12711-bib-0058){ref-type="ref"}, [59](#jcmm12711-bib-0059){ref-type="ref"}, [60](#jcmm12711-bib-0060){ref-type="ref"}, [61](#jcmm12711-bib-0061){ref-type="ref"}, [62](#jcmm12711-bib-0062){ref-type="ref"}. However, a growing number of studies have described indirect intercellular communication by TCs that involves chemical [34](#jcmm12711-bib-0034){ref-type="ref"}, [35](#jcmm12711-bib-0035){ref-type="ref"}, [63](#jcmm12711-bib-0063){ref-type="ref"} and paracrine/juxtacrine signalling [5](#jcmm12711-bib-0005){ref-type="ref"}, [34](#jcmm12711-bib-0034){ref-type="ref"}, [35](#jcmm12711-bib-0035){ref-type="ref"}, [36](#jcmm12711-bib-0036){ref-type="ref"}, [37](#jcmm12711-bib-0037){ref-type="ref"}, [38](#jcmm12711-bib-0038){ref-type="ref"}, extracellular vesicles (EVs) [4](#jcmm12711-bib-0004){ref-type="ref"}, [5](#jcmm12711-bib-0005){ref-type="ref"}, [35](#jcmm12711-bib-0035){ref-type="ref"}, [36](#jcmm12711-bib-0036){ref-type="ref"}, [37](#jcmm12711-bib-0037){ref-type="ref"}, [38](#jcmm12711-bib-0038){ref-type="ref"}, [39](#jcmm12711-bib-0039){ref-type="ref"}, [40](#jcmm12711-bib-0040){ref-type="ref"}, [41](#jcmm12711-bib-0041){ref-type="ref"}, [42](#jcmm12711-bib-0042){ref-type="ref"}, [43](#jcmm12711-bib-0043){ref-type="ref"}, [44](#jcmm12711-bib-0044){ref-type="ref"}, [45](#jcmm12711-bib-0045){ref-type="ref"}, [46](#jcmm12711-bib-0046){ref-type="ref"}, [63](#jcmm12711-bib-0063){ref-type="ref"}, [64](#jcmm12711-bib-0064){ref-type="ref"}, [65](#jcmm12711-bib-0065){ref-type="ref"}, [66](#jcmm12711-bib-0066){ref-type="ref"}, sex hormones [3](#jcmm12711-bib-0003){ref-type="ref"}, [5](#jcmm12711-bib-0005){ref-type="ref"}, [18](#jcmm12711-bib-0018){ref-type="ref"}, [35](#jcmm12711-bib-0035){ref-type="ref"}, [67](#jcmm12711-bib-0067){ref-type="ref"} and/or microRNAs [28](#jcmm12711-bib-0028){ref-type="ref"}, [41](#jcmm12711-bib-0041){ref-type="ref"}, [68](#jcmm12711-bib-0068){ref-type="ref"}, [69](#jcmm12711-bib-0069){ref-type="ref"}, [70](#jcmm12711-bib-0070){ref-type="ref"}. Specifically, EVs and/or exosomes are shed or released from Tps in uterine TCs [4](#jcmm12711-bib-0004){ref-type="ref"}, [5](#jcmm12711-bib-0005){ref-type="ref"}, [43](#jcmm12711-bib-0043){ref-type="ref"}; soluble mediators, such as IL‐6, VEGF and nitric oxide, are secreted from TCs [28](#jcmm12711-bib-0028){ref-type="ref"}, [51](#jcmm12711-bib-0051){ref-type="ref"}, [71](#jcmm12711-bib-0071){ref-type="ref"}; and growth factors, including IL‐6, VEGF, macrophage inflammatory protein 1α (MIP‐1α), MIP‐2 and Monocyte Chemoattractant Protein 1 (MCP‐1), are significantly expressed along with additional cytokines, including IL‐2, IL‐10, IL‐13, and chemokines, such as Growth‐Related Oncogene/Keratinocyte‐derived Chemokine (GRO‐KC), in the secretome of cultured rodent cardiac TCs [71](#jcmm12711-bib-0071){ref-type="ref"}. These paracrine effects might contribute to function‐specific intercellular communication and regulate the activity of neighbouring cells.

Accumulating studies have shown that in both normal and diseased tissues, TCs develop intercellular contacts with various immunocytes, including macrophages, mast cells and lymphocytes [7](#jcmm12711-bib-0007){ref-type="ref"}, [8](#jcmm12711-bib-0008){ref-type="ref"}, [9](#jcmm12711-bib-0009){ref-type="ref"}, [10](#jcmm12711-bib-0010){ref-type="ref"}, [11](#jcmm12711-bib-0011){ref-type="ref"}, [12](#jcmm12711-bib-0012){ref-type="ref"}, [44](#jcmm12711-bib-0044){ref-type="ref"}, [45](#jcmm12711-bib-0045){ref-type="ref"}, [46](#jcmm12711-bib-0046){ref-type="ref"}, [47](#jcmm12711-bib-0047){ref-type="ref"}, [48](#jcmm12711-bib-0048){ref-type="ref"}, [49](#jcmm12711-bib-0049){ref-type="ref"}, [50](#jcmm12711-bib-0050){ref-type="ref"}, [51](#jcmm12711-bib-0051){ref-type="ref"}, [52](#jcmm12711-bib-0052){ref-type="ref"}, [53](#jcmm12711-bib-0053){ref-type="ref"}, [54](#jcmm12711-bib-0054){ref-type="ref"}, [55](#jcmm12711-bib-0055){ref-type="ref"}, [56](#jcmm12711-bib-0056){ref-type="ref"}, [72](#jcmm12711-bib-0072){ref-type="ref"}. Telocytes might modulate the activity of immunocytes through direct intercellular junctional complexes or indirect paracrine communication [45](#jcmm12711-bib-0045){ref-type="ref"}, [46](#jcmm12711-bib-0046){ref-type="ref"}, [47](#jcmm12711-bib-0047){ref-type="ref"}, [48](#jcmm12711-bib-0048){ref-type="ref"}, [49](#jcmm12711-bib-0049){ref-type="ref"}. Telocytes might be active players in local immunoregulation and immunosurveillance, acting as important 'local data suppliers' for the immune response [44](#jcmm12711-bib-0044){ref-type="ref"}, [46](#jcmm12711-bib-0046){ref-type="ref"}, [51](#jcmm12711-bib-0051){ref-type="ref"}, [52](#jcmm12711-bib-0052){ref-type="ref"}. It is conceivable that TCs are involved in the pathological processes of multiple autoimmune, chronic inflammatory and fibrotic disorders, and progressive local loss of TCs might contribute to altered intercellular communication or disrupted immune homeostasis [10](#jcmm12711-bib-0010){ref-type="ref"}, [11](#jcmm12711-bib-0011){ref-type="ref"}, [12](#jcmm12711-bib-0012){ref-type="ref"}, [44](#jcmm12711-bib-0044){ref-type="ref"}, [50](#jcmm12711-bib-0050){ref-type="ref"}, [52](#jcmm12711-bib-0052){ref-type="ref"}, [53](#jcmm12711-bib-0053){ref-type="ref"}, [54](#jcmm12711-bib-0054){ref-type="ref"}, [72](#jcmm12711-bib-0072){ref-type="ref"}.

Infertility is the most common disease that affects women of reproductive age. Among the possible causes of infertility, immune‐mediated fertility problems and related diseases, such as endometriosis, pelvic inflammatory disease and salpingitis, are prevalent in the clinic. We were the first to report [11](#jcmm12711-bib-0011){ref-type="ref"}, [12](#jcmm12711-bib-0012){ref-type="ref"} that TCs were connected to activated immunocytes, including mononuclear cells, mast cells, eosinophils and neutrophils, *via* heterocellular junctions in inflammatory‐affected oviduct tissue from an Spraque‐Dawley (SD) rat model; these data suggested the potential involvement of TCs in local immuno‐inflammatory processes. Through direct heterocellular junctions or indirect paracrine effects, TCs might influence local immunological microenvironments, participate in immunological signal presentation and/or transduction, and contribute to subsequent immune responses and immune‐mediated gynecological diseases or reproductive abnormalities. Nevertheless, no reliable cytological evidence is currently available to support this hypothesis. Herein, we evaluate the *in vitro* paracrine effects of uterine TCs on mouse peritoneal macrophage (pMAC) morphology, viability and cytokine/enzyme production. This study aimed to provide *in vitro* evidence for the immunoregulatory/immunosurveillance roles of uterine TCs.

Materials and methods {#jcmm12711-sec-0002}
=====================

Culture of uterine telocytes {#jcmm12711-sec-0003}
----------------------------

Animal care, surgery and handling procedures were approved by the University Health Network Animal Care Committee. Adult female BALB/c mice (8--10 weeks old, 20--25 g) were provided by the Laboratory Animal Center of Soochow University. All mice were maintained in a specific pathogen‐free environment with *ad libitum* access to food and water before the experiments. To obtain primary uterine TCs, mice were killed with an overdose of sodium pentobarbital (50 mg/kg; Fuyang Pharmaceutical Factory, Fuyang, China), and uterine tissue was removed and rinsed three times with PBS containing 100 U/ml penicillin and 0.1 mg/ml streptomycin (Sigma‐Aldrich, St. Louis, MO, USA). Uterine samples were then placed in a plastic dish containing sterile PBS and subjected to mechanical grinding (with a particle size of \<1 mm^3^); next, tissue fragments were collected in a sterile tube (Corning, New York, USA) and centrifuged at 179 g for 5 min. The supernatants were removed, and the pellet was re‐suspended in DMEM/F12 (Gibco, New York, USA) containing 0.1% collagenase type II (Sigma‐Aldrich). Tissue digestion was performed at 37°C with vigorous shaking at 9 g for 90 min. and gentle agitation using a Pasteur pipette every 15 min. The enzymatic reaction was terminated by the addition of 10% FBS (Gibco). The cells were harvested by centrifugation at 302 g for 10 min., re‐suspended in 5 ml of DMEM/F12 supplemented with 10% FBS and antibiotics, plated in 25 cm^2^ cell culture flasks (Corning), and maintained in a humidified atmosphere containing 5% CO~2~ at 37°C for 90 min. The culture medium was removed, the cells were rinsed twice, and 5 ml of complete medium was added. The medium was changed every 48 hrs, at which point the cells were examined using a microscope (Leica, Heidelberg, Germany).

Methylene blue staining for viability {#jcmm12711-sec-0004}
-------------------------------------

Cultured TCs were washed with pre‐warmed phenol red‐free DMEM/F12, fixed and stained in methylene blue solution (0.05 mg/ml; Sigma‐Aldrich) at 37°C for 20 min., and imaged.

Mitochondrial labelling {#jcmm12711-sec-0005}
-----------------------

MitoTracker Green FM (Beyotime, Shanghai, China) was used to label mitochondria. The cells were incubated in phenol red‐free DMEM with 100 nmol/l MitoTracker Green in a humidified atmosphere with 5% CO~2~ at 37°C for 30 min. Then, the cells were examined and photographed using fluorescence microscopy (450--490 nm excitation, 520 nm barrier filter; Leica).

Immunofluorescence cytochemistry {#jcmm12711-sec-0006}
--------------------------------

Freshly harvested cells were treated with 0.25% Trypsin‐ethylenediaminetetraacetic acid (Gibco) and plated at a low density on coverslips for 48 hrs, followed by fixation in acetone for 2 min., and permeabilization with 0.5% Triton X‐100 for 1 hr. Immunostaining was simultaneously performed with rat anti‐vimentin (1:200; cat. no. ab115189; Abcam, Cambridge, MA, USA) and rabbit anti‐CD34 (1:200; cat. no. ab81289; Abcam). Fixed cells were incubated with the primary antibodies for 90 min. at 37°C and then with goat anti‐rat IgG‐FITC (1:400; cat. no. sc‐2011; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and goat anti‐rabbit IgG‐CY3 (1:400; cat. no. ab97075; Abcam) for 30 min. at 37°C. Finally, the cells were counterstained with DAPI (1:50; cat. no. C1002) and mounted with antifade medium (1:1000; cat. no. p0126; both from Beyotime). Similar procedures were applied for dual antibody labelling with rat anti‐vimentin (1:200; cat. no. ab115189) and rabbit anti‐c‐kit (1:200; cat. no. ab5506; both from Abcam). The stained slides were observed under the aforementioned fluorescence microscope.

Preparation of telocyte conditioned media {#jcmm12711-sec-0007}
-----------------------------------------

Within 3--4 days of primary cell culture, TCs entered the logarithmic growth phase. At this point, the TCs were plated in 6‐well culture plates (1 × 10^6^ cells/well) containing 2.5 ml of serum‐free DMEM/F12. After a 24 hrs incubation at 37°C, TC conditioned media (TCM) was harvested and stored at −80°C.

Isolation and co‐culture of peritoneal macrophages {#jcmm12711-sec-0008}
--------------------------------------------------

Peritoneal macrophages were isolated from BALB/c mice. Briefly, 2 ml of 3% thioglycollate (Sigma‐Aldrich) was injected into the abdominal cavity to activate pMACs and thus enable the harvest of an optimal yield; after 3 days, the mice were killed with an overdose of sodium pentobarbital *via* a subcutaneous injection. Then, 15 ml of cold sterile DMEM/F12 was injected intraperitoneally, and peritoneal lavage fluids were collected using sterile syringes 10 min. later.

The number of pMACs was counted microscopically using trypan blue dye. Then, pMACs were seeded in 96‐well plates (1 × 10^5^ cells/well) and 12‐well plates (1 × 10^6^ cells/well) for cell counting kit 8 (CCK‐8) assays and ELISAs for cytokines/enzymes, respectively. Briefly, after incubation at 37°C for 4 hrs to allow pMACs to adhere to the surface of the plastic culture plates, the non‐adherent cells were removed. The remaining adherent pMACs (\>98%) were cultured with TCM, serum‐free DMEM/F12 (negative control), or serum‐free DMEM/F12 with 0.5 μg/ml lipopolysaccharide (LPS, a classical inflammatory stimulus; positive control) (Sigma‐Aldrich). At 24 and 48 hrs, pMACs from different groups were subjected to morphology and viability assays. Then, culture supernatants were collected by filtration through a microporous film with a 0.22 μm pore size and stored at −80°C for ELISAs for a panel of cytokines/enzymes.

Cell viability assay {#jcmm12711-sec-0009}
--------------------

Ten microliters of CCK‐8 solution (Dojindo Laboratories, Tokyo, Japan) was added to each well containing 100 μl of medium. The absorbance at 450 nm of each well was monitored using a micro‐well plate reader (Multiscan MK3; Thermo Labsystems, Waltham, MA, USA) after a 2 hrs incubation at 37°C.

Measurement of cytokines/enzymes in supernatants {#jcmm12711-sec-0010}
------------------------------------------------

A panel of nine pMAC‐related cytokines/enzymes, including inducible nitric oxide synthase (iNOS), IL‐6, tumour necrosis factor α (TNF‐α), IL1‐R1, IL‐10, transforming growth factor (TGF)‐β1, IL‐1β, IL‐23α and IL‐18, was analysed using commercially available ELISA kits (EIAab, Wuhan, China) according to the manufacturer\'s instructions.

Statistical analysis {#jcmm12711-sec-0011}
--------------------

The data are presented as the mean ± S.D., and the data were analysed by one‐way [anova]{.smallcaps} or Student\'s *t*‐test using SPSS (version 13; SPSS Inc., Chicago, IL, USA), followed by Dunnett\'s test for comparisons between the DMEM/F12 and test groups. *P* \< 0.05 was considered to be statistically significant.

Results {#jcmm12711-sec-0012}
=======

*In vitro* TC identification {#jcmm12711-sec-0013}
----------------------------

After 3 or 4 days of primary cell culture, uterine TCs were clearly identified based on morphology. The TCs had small bipolar or multipolar cellular bodies with one or more extremely long, thin, sinuous cellular projections called Tps, which were composed of alternating thin segments (podomers) and thick segments (podoms). Telocytes use their Tps to establish homocellular contacts with adjacent TCs or Tps (Fig. [1](#jcmm12711-fig-0001){ref-type="fig"}A--C). Furthermore, numerous mitochondria were observed (Fig. [1](#jcmm12711-fig-0001){ref-type="fig"}D), indicating active cell metabolism.

![Phase‐contrast microscopy of typical live TCs in primary culture; mouse uterus. TCs have irregularly shaped cell bodies and long characteristic Tps extending from the cell body, with typical alternating podoms (thick segments) and podomers (thin segments) that form a homocellular network (black arrowhead). (**A** and **B**) phase‐contrast microscopy. (**C**) phase‐contrast microscopy with methylene blue staining. (**D**) TCs with long, thin branches (Tps). High‐intensity fluorescence was observed around the intercellular connections between Tps and other cells, indicating active energy metabolism (white arrow). Fluorescence microscopy, MitoTracker green staining.](JCMM-19-2741-g001){#jcmm12711-fig-0001}

TCs immunodiagnostics {#jcmm12711-sec-0014}
---------------------

Telocytes were stained for vimentin and CD34, and a significant number of vimentin‐positive cells (green) also exhibited CD34‐positive fluorescence (red). Furthermore, the alternating thick and thin segments of Tps could be clearly identified (Fig. [2](#jcmm12711-fig-0002){ref-type="fig"}). However, no fluorescence for c‐Kit (images not shown) was observed.

![Representative double‐labelled immunofluorescence images. Nuclei were counterstained with DAPI (blue). Images of negative staining for c‐kit are not shown; scale bar = 50 μm. (**A**) Positive FITC labelling for vimentin (green). (**B**) Positive CY3 labelling for CD34 (red). (**C**) In the merged image, vimentin and CD34 are co‐localized in TCs, both in the cellular body and in Tps. Podomers and podoms are arrayed along Tps.](JCMM-19-2741-g002){#jcmm12711-fig-0002}

Morphological study of pMACs {#jcmm12711-sec-0015}
----------------------------

After 48 hrs of co‐culture with TCM, DMEM/F12, or LPS (0.5 μg/ml), the morphological changes in pMACs were obviously different (Fig. [3](#jcmm12711-fig-0003){ref-type="fig"}). DMEM/F12‐treated pMACs showed no obvious morphological abnormalities and no sign of activation or an immunoresponse (Fig. [3](#jcmm12711-fig-0003){ref-type="fig"}A). Conversely, TCM‐treated pMACs contained abundant pseudopodia and secretory granules within the cytoplasm, with no obvious cell death after 48 hrs, suggesting a relatively moderate activation/immunoresponse (Fig. [3](#jcmm12711-fig-0003){ref-type="fig"}B). However, more dramatic morphological changes were observed after treatment with LPS, and these changes were accompanied by obvious cell death at 24 hrs, indicating excessive activation or over‐stimulation of pMACs (Fig. [3](#jcmm12711-fig-0003){ref-type="fig"}C).

![Morphological alterations in mouse pMACs following exposure to TCM,DMEM/F12, or LPS for 48 hrs. (**A**) DMEM/F12‐treated pMACs showed no signs of activation: they had normal morphology with a regular round shape, abundant clear cytoplasm and ample intercellular spaces. (**B**) TCM‐treated pMACs had a relatively moderate activation/immune response: they exhibited obvious morphological changes with a polyhedron shape, large and sufficient pseudopodia, abundant granules in the cytoplasm, narrow intercellular spaces and densely populated features. (**C**) LPS (0.5 μg/ml)‐treated pMACs showed excessive activation: they presented with irregular, doublet or multiple shapes and ultimately underwent cell death, which was characterized by cell membrane blebbing, cell body atrophy and nuclear condensation or fragmentation.](JCMM-19-2741-g003){#jcmm12711-fig-0003}

Cell viability of pMACs {#jcmm12711-sec-0016}
-----------------------

One‐way [anova]{.smallcaps} and Dunnett\'s test revealed a significant difference between the TCM and DMEM/F12 treatments as well as between the LPS and DMEM/F12 treatments (both *P* \< 0.05) in terms of their effect on cell viability. However, the slightly higher viability observed for TCM‐treated pMACs compared to LPS‐treated pMACs was not significant (*P* \> 0.05), indicating that TCM and LPS efficiently activated pMACs to the same extent (Fig. [4](#jcmm12711-fig-0004){ref-type="fig"}).

![Cell viability of pMACs after 48 hrs of co‐culture. As demonstrated by increased OD values, TCM and LPS significantly activated pMACs compared to DMEM/F12. Nevertheless, no significant difference was observed between TCM and LPS (*P* \> 0.05), although a slightly higher value was obtained for TCM. \**P* \< 0.05 *versus* DMEM/F12; error bars = SD. The data are representative of at least 9 values from three independent experiments.](JCMM-19-2741-g004){#jcmm12711-fig-0004}

Quantitative analysis of cytokines/enzymes {#jcmm12711-sec-0017}
------------------------------------------

As indicated by one‐way [anova]{.smallcaps} or Student\'s *t*‐test followed by Dunnett\'s test, iNOS and IL‐6 were significantly increased in TCM‐treated pMACs compared to DMEM/F12‐treated pMACs at 24 and/or 48 hrs, but the levels of these proteins were always higher in LPS‐treated cells (all *P* \< 0.05; Fig. [5](#jcmm12711-fig-0005){ref-type="fig"}A and B). Meanwhile, slightly but significantly increased levels of TNF‐α, IL1‐R1, and IL‐10 were observed in TCM‐treated pMACs, but again, these levels were lower than those in the LPS‐treated cells at the two time points (all *P* \< 0.05). However, no obvious fluctuations in TGF‐β1, IL‐1β, IL‐23α and IL‐18 levels were observed throughout the experiment (Fig. [5](#jcmm12711-fig-0005){ref-type="fig"}B).

![Quantitative analysis of nine cytokines/enzymes secreted by pMACs after exposure to TCM,DMEM/F12 or LPS (0.5 μg/ml) for 24 or 48 hrs. The mean and SD were calculated from nine values from three independent experiments. The bars that do not share a letter represent data that are significantly different (*P *\<* *0.05). (**A** and **B**) The concentrations of iNOS and IL‐6 were significantly elevated, and TNF‐α, IL1‐R1 and IL‐10 levels were slightly, but significantly, increased. At 24 or 48 hrs, one‐way [anova]{.smallcaps} revealed significant differences in iNOS,IL‐6, TNF‐α, IL1‐R1 and IL‐10 levels after treatment with TCM,DMEM/F12 or LPS (all *P* \< 0.05). Dunnett\'s test showed significant differences between DMEM/F12 and the test values (all *P* \< 0.05). Student\'s *t*‐test revealed significant differences in the TCM and LPS groups at the 24 and 48 hrs time points (all *P* \< 0.05). (**B**) No significant changes in TGF‐β1, IL‐1β, IL‐23α and IL‐18 were observed. The bars that share a letter were either not significantly different (*P* \> 0.05), or their values were too low for biological significance.](JCMM-19-2741-g005){#jcmm12711-fig-0005}

Discussion {#jcmm12711-sec-0018}
==========

Recent studies have identified new cellular elements in female reproductive organs that are now named TCs [1](#jcmm12711-bib-0001){ref-type="ref"}, [2](#jcmm12711-bib-0002){ref-type="ref"}, [3](#jcmm12711-bib-0003){ref-type="ref"}, [4](#jcmm12711-bib-0004){ref-type="ref"}, [5](#jcmm12711-bib-0005){ref-type="ref"}, [6](#jcmm12711-bib-0006){ref-type="ref"}, [7](#jcmm12711-bib-0007){ref-type="ref"}, [8](#jcmm12711-bib-0008){ref-type="ref"}, [9](#jcmm12711-bib-0009){ref-type="ref"}, [10](#jcmm12711-bib-0010){ref-type="ref"}, [11](#jcmm12711-bib-0011){ref-type="ref"}, [12](#jcmm12711-bib-0012){ref-type="ref"}, [13](#jcmm12711-bib-0013){ref-type="ref"}, [14](#jcmm12711-bib-0014){ref-type="ref"}, [15](#jcmm12711-bib-0015){ref-type="ref"}, [16](#jcmm12711-bib-0016){ref-type="ref"}, [17](#jcmm12711-bib-0017){ref-type="ref"}, [18](#jcmm12711-bib-0018){ref-type="ref"}, [19](#jcmm12711-bib-0019){ref-type="ref"}, [20](#jcmm12711-bib-0020){ref-type="ref"}, [21](#jcmm12711-bib-0021){ref-type="ref"}, [22](#jcmm12711-bib-0022){ref-type="ref"}, [23](#jcmm12711-bib-0023){ref-type="ref"}, [24](#jcmm12711-bib-0024){ref-type="ref"}, [25](#jcmm12711-bib-0025){ref-type="ref"}. Multiple functions have been proposed for uterine TCs, including in modulating the contraction of the myometrium [5](#jcmm12711-bib-0005){ref-type="ref"}, [13](#jcmm12711-bib-0013){ref-type="ref"}, [16](#jcmm12711-bib-0016){ref-type="ref"}, [17](#jcmm12711-bib-0017){ref-type="ref"}, [22](#jcmm12711-bib-0022){ref-type="ref"}, [24](#jcmm12711-bib-0024){ref-type="ref"} and regulating the blood volume in the placenta [2](#jcmm12711-bib-0002){ref-type="ref"}, [10](#jcmm12711-bib-0010){ref-type="ref"}, [19](#jcmm12711-bib-0019){ref-type="ref"}, [25](#jcmm12711-bib-0025){ref-type="ref"} and the self‐renewal of the endometrium or myometrium [4](#jcmm12711-bib-0004){ref-type="ref"}. However, the connectivity between TCs and multiple immunocytes in normal tissue [7](#jcmm12711-bib-0007){ref-type="ref"}, [8](#jcmm12711-bib-0008){ref-type="ref"}, [9](#jcmm12711-bib-0009){ref-type="ref"}, [10](#jcmm12711-bib-0010){ref-type="ref"}, [44](#jcmm12711-bib-0044){ref-type="ref"}, [45](#jcmm12711-bib-0045){ref-type="ref"}, [46](#jcmm12711-bib-0046){ref-type="ref"}, [47](#jcmm12711-bib-0047){ref-type="ref"}, [48](#jcmm12711-bib-0048){ref-type="ref"}, [49](#jcmm12711-bib-0049){ref-type="ref"}, [50](#jcmm12711-bib-0050){ref-type="ref"}, [51](#jcmm12711-bib-0051){ref-type="ref"}, [52](#jcmm12711-bib-0052){ref-type="ref"}, [53](#jcmm12711-bib-0053){ref-type="ref"}, [54](#jcmm12711-bib-0054){ref-type="ref"}, [55](#jcmm12711-bib-0055){ref-type="ref"}, [56](#jcmm12711-bib-0056){ref-type="ref"}, [72](#jcmm12711-bib-0072){ref-type="ref"} and in inflammation‐affected oviduct tissue from an SD rat model [11](#jcmm12711-bib-0011){ref-type="ref"}, [12](#jcmm12711-bib-0012){ref-type="ref"} evoked the hypothesis that TCs might act as antigen processing cells or local data suppliers, thereby promoting signal transduction and triggering immunocyte migration and the immune response (repression or activation). Nevertheless, no reliable *in vitro* evidence is currently available to support an immunoregulatory/immunosurveillance role for TCs.

To confirm the aforementioned *in vivo* findings, primary mouse uterine TCs were cultured, and typical TCs were confirmed both structurally and phenotypically. However, the immunophenotype of mouse uterine TCs varies among reports, possibly because of the existence of different subpopulations of uterine TCs [6](#jcmm12711-bib-0006){ref-type="ref"}. Peritoneal macrophages, one of the most important peritoneal immunocytes related to endometriosis, pelvic pain and infertility [73](#jcmm12711-bib-0073){ref-type="ref"}, were also harvested for a co‐culture study. Multiple morphological changes occurred after culture with either TCM or LPS, generating a similar appearance to macrophages responding to infectious pathogens [74](#jcmm12711-bib-0074){ref-type="ref"}, [75](#jcmm12711-bib-0075){ref-type="ref"}. However, LPS‐treated pMACs underwent more dramatic morphological changes than TCM‐treated cells. This was further demonstrated by the CCK‐8 viability analysis and the overproduction of a panel of macrophage‐derived cytokines/enzyme in the TCM and LPS groups. Peritoneal macrophages are terminally differentiated cells that do not have the potential to proliferate but do have the capacity to activate the immune response. Therefore, we report for the first time that TCM demonstrated the ability to activate pMACs and potentially trigger a subsequent immune response that was similar to, but slightly weaker than, that elicited by the classical stimulus, LPS. We believe that the panel of elevated cytokines/enzymes plays an important role in reproductive physiology.

Inducible nitric oxide synthase, an enzyme that catalyses the production of nitric oxide from L‐arginine upon stimulation by pro‐inflammatory cytokines (*e.g*., IL‐1, tumour necrosis factor α and interferon γ), has been suggested to participate in host immunity and anti‐microbial and anti‐tumour activities as part of the oxidative burst of macrophages [76](#jcmm12711-bib-0076){ref-type="ref"}. Moreover, the pathological generation of nitric oxide through increased iNOS activity may decrease the tubal ciliary beat frequency and oviductal smooth muscle activity, further affecting the intra‐tubal transport of ova or fertilized eggs, which might consequently result in a tubal ectopic pregnancy or tubal factor infertility and most likely causes uterine contractility disorders [77](#jcmm12711-bib-0077){ref-type="ref"}. In the uterus, the local production of nitric oxide plays a role in uterine cyclicity [78](#jcmm12711-bib-0078){ref-type="ref"}, participates in growth associated with the decidual response [79](#jcmm12711-bib-0079){ref-type="ref"}, and reflects embryonic health [80](#jcmm12711-bib-0080){ref-type="ref"}. Generally, elevated nitric oxide values are critical for successful embryo implantation during early pregnancy by promoting vasodilation and smooth muscle relaxation [81](#jcmm12711-bib-0081){ref-type="ref"}. In contrast, nitric oxide production is suppressed in the later stage of gestation to prepare the uterus for parturition [82](#jcmm12711-bib-0082){ref-type="ref"}. Therefore, a balanced iNOS/nitric oxide system is critical for successful early implantation, pregnancy and labor. However, TCM‐induced elevations in iNOS levels might cause several reproductive abnormalities.

Interleukin‐6, a multifunctional cytokine mainly produced by antigen‐processing cells such as macrophages and B cells, functions as a regulator of the immune response and local acute inflammation. IL‐6 has broad functional range, affecting the renewal of endometrial blood vessels and menstrual shedding as well as preparing the endometrium for early embryo implantation events, maturation and expansion of foetal precursors [83](#jcmm12711-bib-0083){ref-type="ref"}, [84](#jcmm12711-bib-0084){ref-type="ref"}. Furthermore, IL‐6 is a physiological mediator of the expression of other genes that have documented or presumed roles in pregnancy, such as stimulating the release of human chorionic gonadotropin from syncytiotrophoblast cells [85](#jcmm12711-bib-0085){ref-type="ref"}, [86](#jcmm12711-bib-0086){ref-type="ref"}. Increased concentrations of IL‐6 are linked to proliferative disorders of the endometrium, such as endometriosis [87](#jcmm12711-bib-0087){ref-type="ref"}. Nevertheless, excessive IL‐6 levels induced by TCM might cause an improper endometrial state and implantation failure.

Tumour necrosis factor α, originally known for its tumour cytotoxicity, is a potent mediator of inflammation. Normal levels of TNF‐α in the uterus contribute to cell adhesion, hormone production and cyclic remodelling of the endometrium, which is mediated by the modulation of endometrial cells and promotes neovascularization [88](#jcmm12711-bib-0088){ref-type="ref"}, [89](#jcmm12711-bib-0089){ref-type="ref"}. Tumour necrosis factor α also prevents inappropriate trophoblast cell invasion into the uterus and promotes the growth of embryonic mesenchymal cells [90](#jcmm12711-bib-0090){ref-type="ref"}, [91](#jcmm12711-bib-0091){ref-type="ref"}. However, the over‐expression of TNF‐α not only stimulates the production of nitric oxide but also causes pathophysiological effects, such as implantation failure and immunologically mediated abortion.

Interleukin‐1R1, one of two known receptors for IL‐1, modulates endometrial receptivity, creates a receptive endometrial epithelium and represents a key molecule for successful implantation [92](#jcmm12711-bib-0092){ref-type="ref"}, [93](#jcmm12711-bib-0093){ref-type="ref"}. Strong expression of IL‐1R1 is related to the risk of developing endometriosis [94](#jcmm12711-bib-0094){ref-type="ref"}. Therefore, the up‐regulation of IL‐1R1 by TCM might create an abnormal peri‐implantation environment and lead to blastocyst implantation failure.

Interleukin‐10 is expressed in the placenta in a gestational age‐dependent manner, and its down‐regulation at term is an important mechanism associated with parturition [95](#jcmm12711-bib-0095){ref-type="ref"}. Interleukin‐10 plays positive roles in protecting pregnancy by decreasing trophoblast cell apoptosis, inflammation and endothelial cell dysfunction; IL‐10 deficiency potentially causes adverse pregnancy outcome and foetal death [96](#jcmm12711-bib-0096){ref-type="ref"}, [97](#jcmm12711-bib-0097){ref-type="ref"}. Therefore, IL‐10 has been considered an essential molecule in the maintenance of a successful pregnancy. However, excessive IL‐10 production in response to TCM might lead to an adverse pregnancy outcome.

Nevertheless, more questions remain, including what mechanism is responsible for the elevated levels of iNOS, IL‐6, TNF‐α, IL‐1R1 and IL‐10. Generally, TCs release at least three types of EVs: exosomes, ectosomes and multivesicular bodies, which contain many secretomes [4](#jcmm12711-bib-0004){ref-type="ref"}, [5](#jcmm12711-bib-0005){ref-type="ref"}, [35](#jcmm12711-bib-0035){ref-type="ref"}, [36](#jcmm12711-bib-0036){ref-type="ref"}, [37](#jcmm12711-bib-0037){ref-type="ref"}, [38](#jcmm12711-bib-0038){ref-type="ref"}, [39](#jcmm12711-bib-0039){ref-type="ref"}, [40](#jcmm12711-bib-0040){ref-type="ref"}, [41](#jcmm12711-bib-0041){ref-type="ref"}, [42](#jcmm12711-bib-0042){ref-type="ref"}, [43](#jcmm12711-bib-0043){ref-type="ref"}, [44](#jcmm12711-bib-0044){ref-type="ref"}, [45](#jcmm12711-bib-0045){ref-type="ref"}, [46](#jcmm12711-bib-0046){ref-type="ref"}, [63](#jcmm12711-bib-0063){ref-type="ref"}, [64](#jcmm12711-bib-0064){ref-type="ref"}, [65](#jcmm12711-bib-0065){ref-type="ref"}, [66](#jcmm12711-bib-0066){ref-type="ref"}, [71](#jcmm12711-bib-0071){ref-type="ref"}. Such essential paracrine mediators protect, enrich and transfer complex multimolecular biological messages from EVs within TCs and Tps, thus helping to achieve the immunoregulatory/immunosurveillance roles of TCM. Notably, supernatants from primary human lung and esophagus TC cultures contained increased concentrations of both VEGF and EGF [47](#jcmm12711-bib-0047){ref-type="ref"}, [57](#jcmm12711-bib-0057){ref-type="ref"}. Additionally, transplanting renal TCs significantly increased the local mRNA levels of several growth factors, including HGF, EGF, PDGF and IGF‐1 [60](#jcmm12711-bib-0060){ref-type="ref"}. More recently, the TC secretome was found to contain a panel of chemokines, cytokines and growth factors [71](#jcmm12711-bib-0071){ref-type="ref"}. Thus, these data provide evidence of paracrine secretion by TCs and suggest their possible role in cell proliferation, differentiation and tissue repair.

Nuclear Factor kappa B (NF‐κB) is the most common downstream effector in pMAC activation. Its activation and phosphorylation leads to an enhanced immuno‐inflammatory response and the synthesis of numerous inflammatory cytokines. Transplanting renal TCs activated the NF‐κB signalling pathway in a renal ischaemia‐reperfusion injury model and up‐regulated the mRNA levels of pro‐inflammatory cytokines, such as IL‐1 and TNF‐α [60](#jcmm12711-bib-0060){ref-type="ref"}. However, the exact pathway and the complex networks responsible for the overproduction of cytokines/enzymes, as well as the crosstalk or reciprocal influence between pMACs and TCM, remain to be fully elucidated.

Conclusion {#jcmm12711-sec-0019}
==========

Our results provide the first preliminary *in vitro* evidence that TCs are not innocent bystanders but are instead potential active players in the induction and maintenance of the inflammatory process. These data support our previously proposed hypothesis that TCs participate in local immunoregulation/immunosurveillance. Meanwhile, it remains unknown whether this immuno‐inflammatory response is localized to only uterine TCs or is systemic. Additionally, it remains to be determined whether the observed modulatory effects of low‐level laser stimulation on TC growth [20](#jcmm12711-bib-0020){ref-type="ref"} represents a novel therapy for TC‐associated abnormalities related to local immunity. Nevertheless, in future studies, animal models must be designed to better clarify the functional consequences and clinical applications of TCs in immune‐mediated fertility problems and other related diseases, thereby strengthening the proposed immunoregulatory/immunosurveillance roles of TCs.
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